Further studies are required concerning the role of hypoxia and oxidative stress in osteosarcoma CSCs’ biological features, in particular those studies involving adequate in vivo models that may uncover unanticipated markers of therapeutic resistance, such as HIF-2α previously reported in a humanized orthotopic model [208]. The gene discussed is EPAS1; the disease is osteosarcoma.